| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/15/1994 | WO1994020131A1 Method of treating hepatitis c in non-responders to interferon treatment |
| 09/15/1994 | WO1994020129A1 Treatment of mycobacterial diseases by administration of bactericidal/permeability-increasing protein products |
| 09/15/1994 | WO1994020128A1 Therapeutic uses of bactericidal/permeability increasing protein products |
| 09/15/1994 | WO1994020127A1 Hla-a2.1 binding peptides and their uses |
| 09/15/1994 | WO1994020126A1 Use of peptides for the manufacture of a medicament |
| 09/15/1994 | WO1994020125A1 Treatment of motor neuron diseases with fibroblast growth factor-5 (fgf-5) |
| 09/15/1994 | WO1994020124A1 Method of cancer treatment |
| 09/15/1994 | WO1994020123A1 Methods and compositions for the inhibition of complement activation |
| 09/15/1994 | WO1994020122A1 A method for treating autoimmune diseases using alpha-interferon and/or beta-interferon |
| 09/15/1994 | WO1994020121A1 Method of inhibiting radiation induced weight and hair loss |
| 09/15/1994 | WO1994020113A1 The human c/ebp gene and vectors for its expression |
| 09/15/1994 | WO1994020095A1 Biologically active ureido derivatives useful as antimetastatic agents |
| 09/15/1994 | WO1994020085A1 Methods and compositions for inhibition of angiogenesis |
| 09/15/1994 | WO1994020083A1 Glycosylation of lipids and lipid-containing particles, and diagnostic and therapeutic methods and materials derived therefrom |
| 09/15/1994 | WO1994020082A1 Use of terbinafine for the therapeutic treatment of pneumocystosis |
| 09/15/1994 | WO1994020069A1 Pulmonary administration of granulocyte colony stimulating factor |
| 09/15/1994 | WO1994020063A2 Pharmaceutical tryptophan containing dipeptide compositions and methods of use thereof |
| 09/15/1994 | WO1994019945A1 Oligonucleotide therapies for modulating the effects of herpesviruses |
| 09/15/1994 | WO1994019944A1 Method of treating immature birds with il-2 |
| 09/15/1994 | WO1994019935A1 Isolation of components of interest from milk |
| 09/15/1994 | WO1994016723A3 Wound healing composition |
| 09/15/1994 | WO1994011510A3 Modulators of hematopoietic progenitor cells |
| 09/15/1994 | WO1994011394A3 Peptides with organo-protective activity, process for their preparation and their use in the therapy |
| 09/15/1994 | WO1994004688A3 Cationic peptides and method for production |
| 09/15/1994 | CA2654420A1 Cloning and recombinant production of vespid venom enzymes, such as phospholiphase and hyaluronidase, and immunological therapies based thereon |
| 09/15/1994 | CA2158037A1 Oligodendroglial trophic factor and methods of use thereof |
| 09/15/1994 | CA2157901A1 Bone stimulating factor |
| 09/15/1994 | CA2157865A1 Glycosylation of lipids and lipid-containing particles, and diagnostic and therapeutic methods and materials derived therefrom |
| 09/15/1994 | CA2157782A1 Gene transfer for treating a connective tissue of a mammalian host |
| 09/15/1994 | CA2157761A1 Use of low density lipoprotein with cytotoxic substances |
| 09/15/1994 | CA2157589A1 The human c/ebp gene and vectors for its expression |
| 09/15/1994 | CA2157510A1 Hla-a2.1 binding peptides and their uses |
| 09/15/1994 | CA2157402A1 Acid cleavable compounds, their preparation and use as bifunctional acid-labile crosslinking agents |
| 09/15/1994 | CA2157379A1 Method of cancer treatment |
| 09/15/1994 | CA2157290A1 Inhibitor of collagenase activity and cosmetic composition containing this inhibitor |
| 09/15/1994 | CA2157215A1 New 4-aminopyridines - processes for their production as well as pharmaceutical agents containing them |
| 09/15/1994 | CA2157010A1 Method for inducing tumor cell death |
| 09/15/1994 | CA2156613A1 Fertility regulation with transforming growth factor beta |
| 09/15/1994 | CA2156090A1 Method of treating immature birds with il-2 |
| 09/15/1994 | CA2153656A1 Peptide boronic acid derivatives having protease inhibiting activity |
| 09/15/1994 | CA2134098A1 Biologically active ureido derivatives useful as antimetastatic agents |
| 09/14/1994 | EP0614985A1 Immunoreagents reactive with a conserved epitope of human immunodeficiency virus type I (HIV-1) GP120 and methods of use |
| 09/14/1994 | EP0614984A2 Human anti-TNF antibodies |
| 09/14/1994 | EP0614982A1 Recombinant vector for the exocellular preparation of single chain antibodies expressed in bacillus subtilis |
| 09/14/1994 | EP0614981A1 Chimeric human interferon-gamma-receptor/immunoglobulin polypeptides |
| 09/14/1994 | EP0614980A1 TAT transdominant variants from human Immunodeficiency virus |
| 09/14/1994 | EP0614978A1 Soluble human Fcgamma receptors, method to prepare them, pharmaceutical compositions containing them, their use as drugs and their diagnostic use |
| 09/14/1994 | EP0614977A2 Huntingtin DNA, protein and uses thereof |
| 09/14/1994 | EP0614975A1 Glycoprotein hormone receptor molecules |
| 09/14/1994 | EP0614974A2 Bone - associated transcription control factor-like protein and process for producing the same |
| 09/14/1994 | EP0614913A2 Dynorphin derivatives |
| 09/14/1994 | EP0614911A1 Compounds having a sulfonamide and an amidinegroup, process for preparation and pharmaceutical compositions comprising them |
| 09/14/1994 | EP0614910A1 Streptogramines in purified form, their preparation and pharmaceutical compositions comprising them |
| 09/14/1994 | EP0614616A2 Composition for treating patients with hepatic disease |
| 09/14/1994 | EP0614489A1 NOVEL HUMAN cdc25 GENES, ENCODED PRODUCTS AND USES THEREFOR |
| 09/14/1994 | EP0614487A1 Dna encoding a glycine transporter and uses thereof |
| 09/14/1994 | EP0614464A1 Peptides and antibodies for treatment of rheumatoid arthritis |
| 09/14/1994 | EP0614379A1 TECHNETIUM-99m LABELED PEPTIDES FOR IMAGING |
| 09/14/1994 | EP0614377A1 Method for diagnosing and treating cancer |
| 09/14/1994 | EP0614374A1 MURINE MONOCLONAL ANTIBODY (5c8) RECOGNIZES A HUMAN GLYCOPROTEIN ON THE SURFACE OF T-LYMPHOCYTES |
| 09/14/1994 | EP0614372A1 Cd8?+ cell antiviral factor |
| 09/14/1994 | EP0614370A1 Fibronectin-containing ophthalmic solution, method of manufacture of an ophthalmic solution, method of preserving an ophthalmic solution, and methods of treatment of ophthalmic wounds |
| 09/14/1994 | EP0614369A1 Pharmaceutical dipeptide compositions and methods of use thereof |
| 09/14/1994 | EP0585224A4 Monoclonal antibodies which bind to secreted and membrane-bound ige, but not to ige on basophils |
| 09/14/1994 | EP0542761B1 Eliminating internal initiation of soluble cd4 gene |
| 09/14/1994 | EP0518960B1 Derivatives of n-phenyl glycinamide, their preparation and medicaments containing them |
| 09/14/1994 | EP0424405B1 Variants of plasminogen activators and processes for their production |
| 09/14/1994 | EP0403591B1 Crf analogs |
| 09/14/1994 | EP0162078B1 Method for isolating a protein from a mixture containing said protein and a conformation specific antibody useful therein |
| 09/14/1994 | CN1092076A Targeted delivery of growth factors for bone regeneration |
| 09/14/1994 | CN1092071A Spiro piperidines and homologs which promote release of growth hormone |
| 09/14/1994 | CN1091955A Hematopoietic facilitatory cells |
| 09/13/1994 | US5346992 Process for isolating human albumin from supernatant IV, in particular IV-4, or from COHN's fraction V or from an analogous supernatant or fraction |
| 09/13/1994 | US5346991 Tissue factor mutants useful for the treatment of myocardial infarction and coagulopathic disorders |
| 09/13/1994 | US5346989 Peptides for use in induction of T cell activation against HIV-1 |
| 09/13/1994 | US5346988 Process for obtaining cellular protein having anti-HIV activity |
| 09/13/1994 | US5346907 Cholecystokinin antagonists used in treatment or prevention of disorders of gastrointestinal, central nervous, appetite regulating or pain regulating systems |
| 09/13/1994 | US5346888 Dipeptide alkyl esters and their uses |
| 09/13/1994 | US5346887 Glaucoma treatment |
| 09/13/1994 | US5346886 For increasing chemical stability and penetration of protease inhibitor in the skin |
| 09/13/1994 | US5346815 Sodium ion binding proteins |
| 09/13/1994 | US5346696 Recombinent Interferon |
| 09/13/1994 | US5346687 Partial reduction of disulfide bonds with stannous compound |
| 09/12/1994 | CA2118661A1 Acyloxyhexanoic acid derivatives |
| 09/11/1994 | CA2118642A1 Bone-associated transcription control factor-like protein and process for producing the same |
| 09/10/1994 | CA2118558A1 Soluble human fc-gamma iii receptors, process for the preparation thereof, pharmaceutical compositions containing same, utilization thereof as medicaments, and diagnostic application thereof |
| 09/10/1994 | CA2116947A1 Composition and method for treating patients with hepatic disease |
| 09/09/1994 | CA2117121A1 Peptides |
| 09/07/1994 | EP0613949A2 Gene encoding chondroitinase ABC and uses therefor |
| 09/07/1994 | EP0613947A2 Mitogenic factor, gene thereof and method of microdetection therefor |
| 09/07/1994 | EP0613946A2 hst-2 Mutein, DNA coding for the same and preparation thereof |
| 09/07/1994 | EP0613945A2 Tumor suppressor gene merlin and uses thereof |
| 09/07/1994 | EP0613944A2 Methods for regulating the immune response using CTLA4-binding molecules and IL4-binding molecules |
| 09/07/1994 | EP0613904A2 Vasoactive intestinal peptide analogs for treating smooth muscle disorders and/or asthma |
| 09/07/1994 | EP0613683A1 Pharmaceutical compositions for systemic administration of erythropoietin via the respiratory system |
| 09/07/1994 | EP0613499A1 Human il-4 mutant proteins |
| 09/07/1994 | EP0613498A1 Receptor derivates with binding sites for human rhinoviruses |
| 09/07/1994 | EP0613496A1 Collagen-like polypeptides |
| 09/07/1994 | EP0613484A1 Bactericidal product, pharmaceutical composition containing same and food additive |
| 09/07/1994 | EP0613377A1 Hemostatic composition for local hemostasis |